Science and Health News

A clinical trial conducted by the IrsiCaixa AIDS Research Institute and the Fight AIDS Foundation has induced HIV control in 5 people who have been in an antiretroviral pause for 5, 13, 17, 20 and 27 weeks, respectively. Usually virus rebounds during the first 4 weeks after treatment interruption. This is the first therapeutic intervention against HIV that has proved to be successful in reeducating the immune system of HIV-infected people, enabling it to keep the virus under control while not taking antiretroviral drugs.

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in mice.

The U. S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system.

In a Stanford-led research report, three participants with movement impairment controlled an onscreen cursor simply by imagining their own hand movements.

Researchers at Oregon State University have discovered that a subset of genes involved in daily circadian rhythms, or the «biological clock," only become active late in life or during periods of intense stress when they are most needed to help protect critical life functions.

A mother gives her toddler three homeopathic pills to relieve her teething pain. Within minutes, the baby stops breathing. «My daughter had a seizure, lost consciousness, and stopped breathing about 30 minutes after I gave her three Hyland’s Teething Tablets," the mother later told the Food and Drug Administration. «She had to receive mouth-to-mouth CPR to resume breathing and was brought to the hospital.»

The discovery of the ‘molecular switch’ that causes inflammatory bowel disease (IBD) and Celiac disease, could lead to more effective new treatments for these life-changing auto-immune conditions, according to researchers from scientists at King’s College London and University College London.

Average life expectancy is set to increase in many countries by 2030 - and will exceed 90 years in South Korea, according to new research.